93 851 (Metronidazole 250 mg)
Pill imprint 93 851 has been identified as Metronidazole 250 mg.
Metronidazole is used in the treatment of bacterial vaginitis; trichomoniasis; bacterial infection; amebiasis; skin infection (and more), and belongs to the drug classes amebicides, miscellaneous antibiotics. There is no proven risk in humans during pregnancy. Metronidazole 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 93 851
- 250 mg
- 9.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|51079-0122||UDL Laboratories Inc|
|00591-3969||Watson Pharmaceuticals, Inc. (now Actavis, Inc)|
|54569-0965||A S Medication Solutions LLC (repackager)|
|66267-0147||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about metronidazole
- Metronidazole capsules
- Metronidazole extended-release tablets
- Metronidazole tablets
- Metronidazole Intravenous (Advanced Reading)
- Metronidazole Oral, Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.